Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects

Non-small cell lung cancer is one of the most common types of malignances worldwide and the main cause of cancer-related deaths. Current treatment for NSCLC is based on surgical resection, chemotherapy, radiotherapy, and targeted therapy, with poor therapeutic effectiveness. In recent years, immune...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Shengjie Tang, Chao Qin, Haiyang Hu, Tao Liu, Yiwei He, Haiyang Guo, Hang Yan, Jun Zhang, Shoujun Tang, Haining Zhou
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2022-01-01
Schriftenreihe:	Cells
Schlagworte:	non-small cell lung cancer immune checkpoint inhibitors PD-1/PD-L1 CTLA-4 immunotherapy biomarkers
Online-Zugang:	https://www.mdpi.com/2073-4409/11/3/320
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!